Helen Dignum

499 total citations
9 papers, 242 citations indexed

About

Helen Dignum is a scholar working on Hematology, Genetics and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Helen Dignum has authored 9 papers receiving a total of 242 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Hematology, 4 papers in Genetics and 4 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Helen Dignum's work include Acute Myeloid Leukemia Research (4 papers), Acute Lymphoblastic Leukemia research (4 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Helen Dignum is often cited by papers focused on Acute Myeloid Leukemia Research (4 papers), Acute Lymphoblastic Leukemia research (4 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Helen Dignum collaborates with scholars based in United Kingdom and Denmark. Helen Dignum's co-authors include Alan K. Burnett, Nigel H. Russell, Robert K. Hills, Tryfonia Mainou‐Fowler, Geoffrey Summerfield, David Bowen, Keith Wheatley, Stephen J. Proctor, William J. Kell and Ann E. Hunter and has published in prestigious journals such as Blood, British Journal of Haematology and Leukemia.

In The Last Decade

Helen Dignum

8 papers receiving 233 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Helen Dignum United Kingdom 6 156 95 85 57 56 9 242
C. Troff Germany 7 224 1.4× 77 0.8× 91 1.1× 57 1.0× 78 1.4× 13 301
Laurence Pearce United Kingdom 7 206 1.3× 72 0.8× 68 0.8× 29 0.5× 40 0.7× 10 288
Vicky Sandhu United States 8 270 1.7× 129 1.4× 79 0.9× 57 1.0× 80 1.4× 15 355
Fernando Roncolato Australia 8 109 0.7× 57 0.6× 48 0.6× 39 0.7× 16 0.3× 17 183
Karolína Perglerová Germany 6 194 1.2× 109 1.1× 91 1.1× 36 0.6× 63 1.1× 15 256
Silja Mack Germany 4 158 1.0× 41 0.4× 89 1.0× 63 1.1× 67 1.2× 6 265
Anne Banos France 10 167 1.1× 127 1.3× 81 1.0× 73 1.3× 33 0.6× 27 261
Bartlomiej Getta United States 6 184 1.2× 64 0.7× 117 1.4× 31 0.5× 54 1.0× 19 236
Raouf Ben Abdelali France 8 145 0.9× 74 0.8× 41 0.5× 55 1.0× 129 2.3× 15 262
Seo-Yeon Ahn South Korea 7 123 0.8× 51 0.5× 47 0.6× 73 1.3× 33 0.6× 26 215

Countries citing papers authored by Helen Dignum

Since Specialization
Citations

This map shows the geographic impact of Helen Dignum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helen Dignum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helen Dignum more than expected).

Fields of papers citing papers by Helen Dignum

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Helen Dignum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helen Dignum. The network helps show where Helen Dignum may publish in the future.

Co-authorship network of co-authors of Helen Dignum

This figure shows the co-authorship network connecting the top 25 collaborators of Helen Dignum. A scholar is included among the top collaborators of Helen Dignum based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Helen Dignum. Helen Dignum is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Hills, Robert K., Ian Thomas, Alan K. Burnett, et al.. (2018). The Achievement of Complete Remission Is Associated with Improved Quality of Life in Non-Intensively Treated Patients with Acute Myeloid Leukemia: Results of the UK NCRI LI-1 Tria. Blood. 132(Supplement 1). 372–372. 2 indexed citations
2.
Dennis, Mike, Nigel H. Russell, Robert K. Hills, et al.. (2015). Vosaroxin and vosaroxin plus low-dose Ara-C (LDAC) vs low-dose Ara-C alone in older patients with acute myeloid leukemia. Blood. 125(19). 2923–2932. 39 indexed citations
5.
6.
Mainou‐Fowler, Tryfonia, Helen Dignum, Katrina Wood, et al.. (2008). A new subtype-specific monoclonal antibody for IAP-survivin identifies high-risk patients with diffuse large B-cell lymphoma and improves the prognostic value of bcl-2. International Journal of Oncology. 32(1). 59–68. 10 indexed citations
7.
Mainou‐Fowler, Tryfonia, Helen Dignum, Stephen J. Proctor, & Geoffrey Summerfield. (2003). The Prognostic Value of CD38 Expression and its Quantification in B Cell Chronic Lymphocytic Leukemia (B-CLL). Leukemia & lymphoma. 45(3). 455–462. 31 indexed citations
8.
Dignum, Helen, Geoffrey Summerfield, Stephen Proctor, & Tryfonia Mainou‐Fowler. (2003). Quantification of CD38 Expression in B-cell Chronic Lymphocytic Leukemia (B-CLL): a Comparison Between Antibody Binding Capacity (ABC) and Relative Median Fluorescence (RMF). Leukemia & lymphoma. -1(1). 1–1. 4 indexed citations
9.
Mainou‐Fowler, Tryfonia, Helen Dignum, Penelope R. A. Taylor, et al.. (2002). Quantification improves the prognostic value of CD38 expression in B‐cell chronic lymphocytic leukaemia. British Journal of Haematology. 118(3). 755–761. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026